What is Anhui Huaren Health Pharmaceutical Co., Ltd.'s (301408.SZ) StockRank?

MoatMap's StockRank for Anhui Huaren Health Pharmaceutical Co., Ltd. (301408.SZ) is 72/100, with a Buy signal. This is a composite score combining Quality (69), Value (54), and Momentum (41) factor ranks across MoatMap's 20,000+ stock universe.

Does Anhui Huaren Health Pharmaceutical Co., Ltd. have an economic moat?

Anhui Huaren Health Pharmaceutical Co., Ltd. (301408.SZ) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Anhui Huaren Health Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Anhui Huaren Health Pharmaceutical Co., Ltd. (301408.SZ) is Buy, based on a StockRank of 72/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Anhui Huaren Health Pharmaceutical Co., Ltd. in?

Anhui Huaren Health Pharmaceutical Co., Ltd. (301408.SZ) operates in the Healthcare sector, specifically the Pharmaceutical Retailers industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

301408.SZ

BUYGet insider-trade alerts

Anhui Huaren Health Pharmaceutical Co., Ltd. · Healthcare · China · $835M · Avg Vol: $32M/d

StockRank

P/E (TTM)

26.7x

ROE

10.8%

D/E

0.6x

Dividend %

0.7%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

COMPANY DESCRIPTION

Anhui Huaren Health Pharmaceutical Co., Ltd. operates a large-scale pharmaceutical retail chain and wholesale distribution network, primarily in Anhui province. The company's competitive advantage is built on its dense regional store network, vertically integrated supply chain, and strong brand equity in community healthcare. It is a leading regional pharmaceutical retailer expanding its digital and O2O (online-to-offline) healthcare services.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM
Revenue	480.5M	559.3M	667.4M	808.1M	18.9%	830.8M
EPS	0.07	0.04	0.05	0.07	0.7%	0.08
Shares	340.0M	400.0M	400.0M	400.0M	+17.6%	400.0M
Debt	112.2M	197.0M	191.5M	199.1M	21.0%	187.2M
Equity	139.5M	286.2M	295.3M	308.8M	30.3%	—
Op CF	25.6M	19.3M	84.2M	123.3M	68.9%	114.6M
Inv CF	-19.1M	-118.7M	-71.7M	-95.3M	—	—
Fin CF	4.7M	167.4M	-52.4M	-36.0M	—	—

Loading 1Y...

PRICE (1Y)-11.6%

SMA 50SMA 200

$2.24

RSI (14)

44.4

52W High

$4.36

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

11.6%78.0

ROE

10.8%73.6

GP/Assets

35.1%74.5

Op. Margin

8.6%63.0

FCF/Assets

9.8%86.0

Piotroski

893.5

Int. Cover

10.7x61.4

D/E Ratio

0.57x29.5

Current Ratio

1.13x14.6

Value

P/E (TTM)

26.7x41.9

EV/EBITDA

13.2x50.8

P/FCF

10.6x80.5

P/B

2.6x48.1

P/S

1.0x82.6

Div Yield

0.7%15.2

Momentum

52W High %

51%23.1

RS 6M

-32%31.5

SMA 50/200

1.01x67.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

30%67.8

FUNDAMENTALS

Market Cap

$835M

P/E (Forward)

—

Gross Margin

34.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 301408.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
301408.SZ	Anhui Huaren Health Pharmaceutical Co., Ltd.(you)	$835M	72	BUY
9885.HK	YSB Inc.	$356M	77	BUY
002727.SZ	Yixintang Pharmaceutical Group Co., Ltd.	$852M	95	STRONG BUY
002788.SZ	Luyan Pharma Co.,Ltd.	$575M	53	HOLD
603883.SS	LBX Pharmacy Chain Joint Stock Company	$1.2B	93	STRONG BUY
301017.SZ	ShuYu Civilian Pharmacy Corp., Ltd.	$783M	41	HOLD
603233.SS	DaShenLin Pharmaceutical Group Co., Ltd.	$2.5B	99	STRONG BUY
603939.SS	Yifeng Pharmacy Chain Co., Ltd.	$3.2B	98	STRONG BUY
6618.HK	JD Health International Inc.	$13.0B	84	STRONG BUY
6086.HK	Fangzhou Inc.	$124M	32	SELL

Peer medians: ROE 4.8% · P/E 26.5x · Gross margin 52.5%

Anhui Huaren Health Pharmaceutical Co., Ltd. (301408.SZ) — Stock Score Summary

Anhui Huaren Health Pharmaceutical Co., Ltd. (301408.SZ) has a MoatMap StockRank of 72/100 based on Quality (69/100), Value (54/100), and Momentum (41/100) factor scores. The current signal is BUY.

Key Financial Metrics

Price	$2.24
Market Cap	$835M
P/E (TTM)	26.74
Price/Book	2.60
Return on Equity	10.8%
Return on Invested Capital	11.6%
Debt/Equity	56.64
Gross Margin	34.1%
Operating Margin	8.6%
Revenue Growth	12.2%
Dividend Yield	0.7%
Free Cash Flow	$79M

Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the Pharmaceutical Retailers industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Anhui Huaren Health Pharmaceutical Co., Ltd.’s (301408.SZ) StockRank?: MoatMap’s StockRank for Anhui Huaren Health Pharmaceutical Co., Ltd. (301408.SZ) is 72/100, with a Buy signal. It is a composite of Quality (69), Value (54), and Momentum (41) factor ranks across MoatMap’s 20,000+ stock universe.
Does Anhui Huaren Health Pharmaceutical Co., Ltd. have an economic moat?: Anhui Huaren Health Pharmaceutical Co., Ltd. (301408.SZ) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Anhui Huaren Health Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Anhui Huaren Health Pharmaceutical Co., Ltd. (301408.SZ) is Buy, based on a StockRank of 72/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Anhui Huaren Health Pharmaceutical Co., Ltd. in?: Anhui Huaren Health Pharmaceutical Co., Ltd. (301408.SZ) operates in the Healthcare sector, specifically the Pharmaceutical Retailers industry (China).